Skip to main content
. 2018 Dec 19;58(5):849–858. doi: 10.1093/rheumatology/key361

Fig. 2.

Fig. 2

Mean change from baseline in ALT ± s.e. in ASCERTAIN

aPatients in the 4/8 mg/kg q4w i.v. group increased their dose to 8 mg/kg at week 4 and remained on 8 mg/kg for the remainder of the study. ALT: alanine aminotransferase; BL: baseline; q2w: every 2 weeks; q4w: every 4 weeks.